Bollard Group LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 263 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bollard Group LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2020$1,121,000
+20.9%
10,0000.0%0.04%
+27.3%
Q3 2020$927,000
+18.8%
10,0000.0%0.03%
+6.5%
Q2 2020$780,000
+33.3%
10,0000.0%0.03%
+19.2%
Q1 2020$585,000
-27.0%
10,0000.0%0.03%0.0%
Q4 2019$801,000
+9.0%
10,0000.0%0.03%0.0%
Q3 2019$735,000
-80.6%
10,000
-78.9%
0.03%
-81.8%
Q1 2019$3,786,000
+48.5%
47,3000.0%0.14%
+27.7%
Q4 2018$2,550,000
-28.2%
47,300
+4.0%
0.11%
-21.7%
Q3 2018$3,552,000
+5.6%
45,500
-14.2%
0.14%
-7.7%
Q2 2018$3,364,000
-4.1%
53,000
+38.6%
0.16%
-10.9%
Q1 2018$3,508,00038,2500.17%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders